Results 71 to 80 of about 21,184 (254)
Tumor Ca2+ interference therapy suffers from self‐protective Ca2+ metabolic autoregulation. In this scenario, a versatile metal‐phenolic nanocluster (TCMH) is engineered to modulate mitochondrial calcium uniporter (MCU) ‐mediated mito‐Ca2+ metabolic autonomy.
Ronglong Chen +13 more
wiley +1 more source
Reductive Mobilization of Iron from Intact Ferritin: Mechanisms and Physiological Implication
Ferritins are highly conserved supramolecular protein nanostructures composed of two different subunit types, H (heavy) and L (light). The two subunits co-assemble into a 24-subunit heteropolymer, with tissue specific distributions, to form shell-like ...
Fadi Bou-Abdallah +3 more
doaj +1 more source
Use of a Chelating Agent for Accelerating Excretion of Radio-Iron
Summary1. Excretion of parenterally administered radio-iron is approximately 5 to 10 times as great in feces as in urine. The rate of excretion varies with the location of the tracer within the various iron pools in the body, (for example, cells, liver, reticulo-endo-thelial system, etc.).
H, FOREMAN +3 more
openaire +2 more sources
Conjugated poly(imide dioxime)‐based microspheres establish a radiometal coordination‐driven conformational interlocked network with ultra‐high radiostability. This platform enables low‐temperature, multi‐radionuclide labeling for SPECT/PET/MRI imaging and radionuclide therapy. Mechanistic insights from EXAFS and DFT reveal enhanced stability, while in
Xiao Xu +10 more
wiley +1 more source
A NIR‐II light‐activatable thermoelectric nanoreactor converts surface‐bound Cu2+ into bioactive Cu+ via directed electron flow. This spatiotemporally controlled reduction triggers potent cuproptosis and immunogenic cell death, eradicating primary tumors and, together with aPD‐1 therapy, suppressing metastases while establishing durable immune memory ...
Boyu Yuan +10 more
wiley +1 more source
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine. [PDF]
Hašková P +7 more
europepmc +1 more source
SYNTHETIC CHELATING AGENTS IN IRON METABOLISM* [PDF]
F, CLETON, A, TURNBULL, C A, FINCH
openaire +2 more sources
This overview summarizes versatile 2D layered materials for AZIB anodes, cathodes, separators and electrolytes, illustrating their dendrite/side reaction suppression mechanisms, and analyzes existing hurdles to propose scalable commercial research outlooks.
Shuge Dai +7 more
wiley +1 more source
Synthesis of Deferiprone as a Widely Used Iron-Chelating Drug for the Treatment of Iron-Overload Diseases [PDF]
Thalassemia is a genetic disease that significantly affects human health. The common treatment of thalassemia is the regular injection of red blood cell, which is associated with the accumulation of iron in different tissues of the body, and makes ...
Sara Sadeghian +3 more
doaj +1 more source
Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major. [PDF]
Nuzzi R +5 more
europepmc +1 more source

